CHOP-led research study identifies key target in treatment-resistant hemophilia A ...Middle East

- News
CHOP-led research study identifies key target in treatment-resistant hemophilia A
Researchers at Children's Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A. The target, known as B cell activating factor (BAFF), appears to promote antibodies against and inhibitors of the missing blood clotting factor that is given to these patients to control their bleeding episodes.

Hence then, the article about chop led research study identifies key target in treatment resistant hemophilia a was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CHOP-led research study identifies key target in treatment-resistant hemophilia A )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News